Form D · Biotechnology

Anavatos Bio Inc.

Seattle, WA · CIK 0002067551

Offering snapshot reported Jul 20, 2026 · SEC filing

Reported sold
$393K
Indefinite offering
Investors reported
4
Form D · investor count
Minimum accepted
$2.5K
Reported outside-investor minimum
First sale
Apr 27, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$196K$393KMay 9, 2025: $42,500.00May 9, 2025Jul 20, 2026: $392,500.00Jul 20, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$42,500 → $392,500

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 20, 2026Amendment$392,500$350,000vs May 9, 20254SEC filing
May 9, 2025Initial$42,500No comparison4SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-545657
Simple Agreement for Future Equity

Source: Form D, filed Jul 20, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Leah Klein Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2314 North 46 Th Street
Seattle, WA, 98103
Phone: 206 437 3169